Analyzing the economic ramifications of the broad implementation of generic prasugrel

31 August 2024 (18:00 - 18:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Filipa Gerardo

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

4 More presentations in this session

Presentation thumbnail

Cardiovascular risk factors and disease mortality among asian american subgroups

Doctor R. Aggarwal (Boston, US)

Abstract Slides Video

Presentation thumbnail

Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis

Associate Professor A. Nelson (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Mortality rate of percutaneous coronary interventions in st-segment elevation myocardial infarction patients under the public health insurance schemes of thailand

Mr S. Chumsantivut (Bangkok, TH)

Abstract Slides Video

Presentation thumbnail

Air pollution and cerebrovascular diseases - retrospective analysis of 10,486 cases of acute ischemic stroke requiring intravenous thrombolysis. A report from the EP-PARTICLES study

Mr M. Swieczkowski (Bialystok, PL)

Abstract Slides Video

Access the full session

Session thumbnail

Mapping cardiovascular health: risk factors, interventions, and geographic insights

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET

You may be interested in

Congress Presentation

The first year of generic NOACs: implications for patients and the healthcare system

Congress Presentation

Implementation of prasugrel and prognostic outcomes after percutaneous coronary intervention for myocardial infarction: a nationwide observational study

Congress Presentation

Is prasugrel preferred over ticagrelor?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources